Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

180979 Press Releases
DateTitleCompany
20 Sep 17 PureTech Health Notes U.S. Patent Issuance Broadly Covering Methods of Assessing Mental and Physical Condition from Human Speech PureTech Health plc,
Published by
Business Wire
20 Sep 17 argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in immune thrombocytopenia Published by
GlobeNewswire
20 Sep 17 Telix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET Technology Published by
GlobeNewswire
20 Sep 17 Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd. Arcus Biosciences,
Published by
Business Wire
20 Sep 17 Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million Published by
GlobeNewswire
20 Sep 17 Ohio’s Yes on Issue 2: U.S. Consumers Pay $84,000 for a Drug Egyptians Buy for $83!! Ohio Taxpayers for Lower Drug Prices,
Published by
Business Wire
20 Sep 17 Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals Published by
GlobeNewswire
20 Sep 17 Acer Therapeutics and Opexa Therapeutics Close Merger and Financing Published by
GlobeNewswire
20 Sep 17 TerrAscend Provides Update on Convertible Debenture Published by
GlobeNewswire
19 Sep 17 Iovance Biotherapeutics, Inc. Announces Public Offering of Common Stock Published by
GlobeNewswire
19 Sep 17 FibroGen Appoints Gerald Lema to Board of Directors Published by
GlobeNewswire
19 Sep 17 ÉLÉPHANT VERT and Marrone Bio Innovations Sign Distribution Agreement in North Africa Published by
GlobeNewswire
19 Sep 17 Relievant Medsystems Names Kevin Hykes Chief Executive Officer Published by
GlobeNewswire
19 Sep 17 Paratek Pharmaceuticals, Inc. to Host Investor Day on October 17, 2017 Published by
GlobeNewswire
19 Sep 17 Krystal Biotech Announces Pricing of Upsized Initial Public Offering Published by
GlobeNewswire
19 Sep 17 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference Published by
GlobeNewswire
19 Sep 17 Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference Published by
GlobeNewswire
19 Sep 17 Zafgen to Present at the 2017 Ladenburg Thalmann Healthcare Conference Published by
GlobeNewswire
19 Sep 17 American Renal Associates Holdings, Inc. Names Don E. Williamson, M.D. as Chief Operating Officer American Renal Associates Holdings, Inc.,
Published by
Business Wire
19 Sep 17 Acceleron Announces Proposed Public Offering of Common Stock Acceleron Pharma Inc.,
Published by
Business Wire
19 Sep 17 Lipocine to Present at the Ladenburg Thalmann 2017 Healthcare Conference Published by
GlobeNewswire
19 Sep 17 Revance to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference Revance Therapeutics, Inc.,
Published by
Business Wire
19 Sep 17 Exelixis to Present at the Cantor Fitzgerald Healthcare Conference on September 25 Exelixis, Inc.,
Published by
Business Wire
19 Sep 17 Aurinia to Host R&D Day and Webcast on October 20th in New York, NY Aurinia Pharmaceuticals Inc.,
Published by
Business Wire
19 Sep 17 Cerveau Technologies, Inc. Announces Collaboration with Banner Health Cerveau Technologies, Inc.,
Published by
Business Wire
19 Sep 17 Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference Novavax, Inc.,
Published by
GlobeNewswire
19 Sep 17 Endocyte to Present at the 2017 Cantor Global Healthcare Conference Published by
GlobeNewswire
19 Sep 17 Gemphire Announces Plans to Advance Gemcabene into Phase 3 Clinical Development Published by
GlobeNewswire
19 Sep 17 Marinus Pharmaceuticals Announces closing of Public Offering of Common Stock and full exercise of underwriter’s option to purchase additional shares Published by
GlobeNewswire
19 Sep 17 Calithera Biosciences Announces CB-839 in Combination with Nivolumab Phase 1/2 Data Accepted for Oral Presentation at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.